These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31932174)

  • 1. Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia.
    Li J; Zhang X; Tang X; Xiao W; Ye F; Sha W; Jia Q
    Schizophr Res; 2020 Apr; 218():295-297. PubMed ID: 31932174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
    Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
    Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-Derived neurotrophic factor (BDNF) plasma level increases in patients with resistant schizophrenia treated with electroconvulsive therapy (ECT).
    Shahin O; Gohar SM; Ibrahim W; El-Makawi SM; Fakher W; Taher DB; Abdel Samie M; Khalil MA; Saleh AA
    Int J Psychiatry Clin Pract; 2022 Nov; 26(4):370-375. PubMed ID: 35192426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
    Karamustafalioglu N; Genc A; Kalelioglu T; Tasdemir A; Umut G; Incir S; Akkuş M; Emul M
    J Psychopharmacol; 2015 Aug; 29(8):898-902. PubMed ID: 25827643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
    Freire TF; Fleck MP; da Rocha NS
    Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms.
    Martinotti G; Ricci V; Di Nicola M; Caltagirone C; Bria P; Angelucci F
    J ECT; 2011 Mar; 27(1):e44-6. PubMed ID: 21206369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum levels of brain-derived neurotrophic factor with electroconvulsive therapy and pharmacotherapy and its clinical correlates in male schizophrenia patients.
    Akbas I; Balaban OD
    Acta Neuropsychiatr; 2022 Apr; 34(2):99-105. PubMed ID: 34924073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia-A Systematic Review and Meta-Analysis.
    Szota AM; Kowalewska B; Ćwiklińska-Jurkowska M; Dróżdż W
    J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia.
    Angelucci F; Mathé AA; Aloe L
    Prog Brain Res; 2004; 146():151-65. PubMed ID: 14699963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
    Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of electroconvulsive therapy and magnetic seizure therapy in schizophrenia: Structural changes/neuroplasticity.
    Li J; Zhang X; Jiang J; Zhang B; Tang Y; Zhang T; Jia Y; Li Q; Xia M; Sheng J; Li C; Wang J
    Psychiatry Res; 2022 Jun; 312():114523. PubMed ID: 35378453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome.
    van Zutphen EM; Rhebergen D; van Exel E; Oudega ML; Bouckaert F; Sienaert P; Vandenbulcke M; Stek M; Dols A
    Transl Psychiatry; 2019 May; 9(1):155. PubMed ID: 31127089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effectiveness of rehabilitation of people diagnosed with schizophrenia using clinical tools, psychological tests, QEEG, and the brain-derived neurotrophic factor (BDNF).
    Markiewcz RA; Markiewicz-Gospodarek A; Kozioł M; Szulecka B; Olajossy M; Plech T
    Psychiatr Pol; 2019 Dec; 53(6):1275-1292. PubMed ID: 32017817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
    Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
    J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
    Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression: A Preliminary Report.
    Mindt S; Neumaier M; Hellweg R; Sartorius A; Kranaster L
    J ECT; 2020 Sep; 36(3):193-197. PubMed ID: 32118691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with mental disorders: A systematic review and meta-analysis.
    Wang Z; Zou Z; Xiao J; Min W; Nan LP; Yuan C; Yuan L; Yang C; Huang R; He Y
    Gen Hosp Psychiatry; 2023; 83():86-92. PubMed ID: 37148598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electroconvulsive therapy in treatment of resistant schizophrenia: biological markers of efficacy and safety].
    Ivanov MV; Zubov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):92-97. PubMed ID: 31089103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.